✦ LIBER ✦

Concurrent chemoradiotherapy with or without adjuvant chemotherapy in intermediate and locoregionally advanced nasopharyngeal carcinoma

✍ Scribed by Wendong Zhang, Huiqin Dou, Chileong Lam, Jixi Liu, Jianfeng Zhou…

Book ID: 120719462
Publisher: S. Karger AG
Year: 2013
Tongue: English
Weight: 314 KB
Volume: 34
Category: Article
ISSN: 1010-4283
DOI: 10.1007/s13277-013-0710-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concurrent chemoradiotherapy plus adjuva

Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial

✍ Lei Chen; Chao-Su Hu; Xiao-Zhong Chen; Guo-Qing Hu; Zhi-Bin Cheng; Yan Sun; Wei- 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 210 KB

Clinical observation of concurrent radio

Clinical observation of concurrent radio-chemotherapy combined with adjuvant chemotherapy in treating locoregionally advanced nasopharyngeal carcinoma

✍ Yan-ping Chen; Yun-cong Liu 📂 Article 📅 2010 🏛 Springer-Verlag ⚖ 298 KB

Concurrent chemoradiation followed by ad

Concurrent chemoradiation followed by adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma in Korea

✍ Kyong Hwa Park; Jeong Sun Kim; Yong Park; Hee Yeon Seo; Young Je Park; In Keun C 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 214 KB

Chemotherapy with or without radiotherap

Chemotherapy with or without radiotherapy in patients with locoregionally recurrent nasopharyngeal carcinoma

✍ Zee-Wan Wong; Eng-Huat Tan; Swee-Peng Yap; Terence Tan; Swan-Swan Leong; Kam-Wen 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

## Background: Treatment of locoregionally recurrent nasopharyngeal carcinoma (npc) is challenging because of prior radiotherapy, morbidities from disease recurrence, and limited therapeutic options available. ## Methods: A retrospective study of patients with locoregionally recurrent npc. ## Re

OP0010 Induction chemotherapy plus concu

OP0010 Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: Preliminary results of a phase 3 multicentre randomised controlled trial

✍ Ma, J.; Chen, N.-Y.; Zhang, N.; Hu, G.-Q.; Sun, Y.; Chen, X.-Z.; Li, J.-G.; Zhu, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Experience with combination of cetuximab

Experience with combination of cetuximab plus intensity-modulated radiotherapy with or without chemotherapy for locoregionally advanced nasopharyngeal carcinoma

✍ Xiaoshuang Niu, Chaosu Hu, Lin Kong 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 381 KB